Paper from Young Pharmacy Researchers Honored
September 12, 2023

A paper from a team of University of Michigan pharmacy residents, students and faculty won the Editor’s Choice Award from the journal Pharmacotherapy.

Study Explores Prevalence of Drug-Gene Interactions, Offers Recommendations for Implementing Pharmacogenetics Services
February 27, 2023
DNA inside pill capsule
“Everyone has the possibility of experiencing a drug gene interactions and we are still learning the best way to identify these individuals and develop strategies for personalized treatment,” says first author Dr. Amy Pasternak.
A key focus of Precision Health, drug gene interactions occur when a patient’s genome impacts how their body processes a drug.
Older Adults Are Missing Out on a Crucial Medication Review Service
July 21, 2022
Lead author Antoinette Coe, PharmD, PhD, Assistant Professor of Clinical Pharmacy
Most older adults take multiple drugs but 80% haven’t had a medication review to check safety and potential savings, and 83% them don’t realize it may be covered by insurance.
Common Plant Fiber Gel Doubled Rate of Tumor Eradication
July 1, 2021
Many people don’t realize that the trillions of bacteria, viruses, and fungi residing within the gastrointestinal tract—collectively called the gut microbiome—are connected to overall health, and specifically to cancer.
New Protein Engineering Method Could Accelerate the Discovery of COVID-19 Therapeutics
July 1, 2021
Discovering and engineering nanobodies with properties suitable for treating human diseases ranging from cancer to COVID-19 is a time-consuming, laborious process.
Dr. Jasmine Luzum Publishes Review of Pharmacogenomics for COVID-19 Therapies
September 3, 2020
Dr. Jasmine Luzum
The goal of Dr. Luzum’s research is to use precision medicine, particularly genetics, to improve cardiovascular outcomes from medications. Adverse cardiac outcomes from drugs used to treat COVID-19 have recently been a major concern.

The COVID-19 pandemic continues to impact global health and safety. Numerous drugs are under expedited investigations, without well-established safety or efficacy data.

Drug That Calms 'Cytokine Storm' Linked to Lower Risk of Death Among COVID-19 Patients on Ventilators
July 13, 2020
Patients who received single intravenous dose of tocilizumab were also more likely to leave the hospital or be off ventilator within a month, despite double the risk of additional infection

Pages